AndraTec PMCF Study : Investigating the AndraTec Guidewires,PTA Balloons and Stents in Iliac Disease.

Inclusion Criteria: \- Corresponding to the CE-mark indications/contra-indications and according to the current medical guidelines for minimally invasive peripheral interventions. Patient is willing to comply with specified follow-up evaluations at the specified times for the duration of the study (depending on the used device during the procedure) Patient is \>18 years old Patient understands the nature of the procedure and provides written informed consent, prior to enrolment in the study Patient is eligible for treatment with * the Lokum L-Quest guidewire * and/or the Lokum Amplatz guidewire * and/or the Slider Hydrophilic Nitinol Guidewire * and/or the AltoSa-XL PTA balloon * and/or the AltoSa-XL Gemini balloon catheter * and/or the Optimus-XL CoCr Bare Metal Stent * and/or the Optimus-XL CVS PTFE Covered Stent, as described in the IFU for each device. Exclusion Criteria: * Application in coronary, cerebral arteries and central circulatory system * Known contraindication to peripheral arterial and visceral vasculature treatment - Anatomy or size of vessels that will not allow appropriate usage of the investigational devices, following IFU of the investigational devices. * Known contraindication and/or allergy to (a component of) an investigational device * Pregnant women and women with childbearing potential not taking adequate contraceptives or currently breastfeeding * Life expectancy of less than twelve months * Any planned surgical intervention/procedure within 30 days of the study procedure * Any patient considered to be hemodynamically unstable at onset of procedure * Patient is currently participating in another investigational drug or device study that has not completed the entire follow-up period. Device-related exclusion criteria (not applicable for guidewire): * Known contraindications given in the IFU of Optimus CoCr and Optimus-CVS PTFE- Covered Balloon-Expandable Stent which includes treatment of renal arteries, aneurysms adjacent to site of stent implantation and neurovascular treatment * Known contraindications given in the IFU of AltoSa-XL-PTA and AltoSa-XL-Gemini Balloon catheter: * patients with a contraindication for anti-platelet/anti-coagulant therapy * patients with excessive vessel tortuosity * dilatation of in-stent restenosis and highly calcified stenosis * patients with perforated vessels evidenced by extravasation of contrast media * patients with a known hypersensitivity to nylon